Novartis
NVS
NVS
1,093 hedge funds and large institutions have $23.5B invested in Novartis in 2019 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 180 increasing their positions, 852 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less funds holding in top 10
Funds holding in top 10: 39 → 29 (-10)
27% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 84
79% less repeat investments, than reductions
Existing positions increased: 180 | Existing positions reduced: 852
Holders
1,093
Holding in Top 10
29
Calls
$228M
Puts
$120M
Top Buyers
| 1 | +$89.9M | |
| 2 | +$44M | |
| 3 | +$39.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$35.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$33.6M |
Top Sellers
| 1 | -$1.02B | |
| 2 | -$578M | |
| 3 | -$300M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$220M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$201M |